Suchergebnisse - "Faderl, Stefan"

PubPharm (596)

1

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment : Phase 1 Trial

enthalten in: Cancers | 2024

von Solomon, S. | Powell, B. | Koprivnikar, J. | +10

2

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML : post hoc analysis of a randomized, phase 3 trial

enthalten in: Journal of hematology & oncology | 2022

von Cortes, J. | Lin, T. | Asubonteng, K. | +3

3

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial

enthalten in: Journal of hematology & oncology | 2022

von Cortes, J. | Lin, T. | Asubonteng, K. | +3

4

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial

enthalten in: Journal of hematology & oncology | 2022

von Cortes, J. | Lin, T. | Asubonteng, K. | +3

5

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML

enthalten in: Blood advances | 2022

von Uy, G. | Newell, L. | Lin, T. | +5

ErratumIn: Blood Adv. 2023 Jun 27;7(12):2715-2717. - PMID 37318935

6

LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERS

enthalten in: Europäisches Patentamt | 2022

von WANG QI | CHEUNG RONALD | FADERL STEFAN

7

TREATMENT OF HEMATOLOGICAL DISORDERS

enthalten in: Europäisches Patentamt | 2022

von FADERL STEFAN

8

LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERS

enthalten in: Europäisches Patentamt | 2021

von CHEUNG RONALD | FADERL STEFAN | WANG QI

9

Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)

enthalten in: Leukemia & lymphoma | 2021

von Jacoby, M. | Finn, L. | Emadi, A. | +6

10

LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERS

enthalten in: Europäisches Patentamt | 2021

von VONG QUEENIE | CHEUNG RONALD | FADERL STEFAN

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[60]